Cumberland Tries To Shut Down Sagent's Generic Acetadote
Tennessee drugmaker Cumberland Pharmaceuticals Inc. launched a patent infringement suit in Delaware federal court Tuesday challenging an effort by Sagent Pharmaceuticals Inc. and Sagent Agila LLC to win U.S. regulatory approval...To view the full article, register now.
Already a subscriber? Click here to view full article